P21 vs Normoftal
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: P021, Ac-DGGLAG-NH2
P21 (also written P021) is a small synthetic peptide reverse-engineered from the most active region of ciliary neurotrophic factor (CNTF), with an adamantane group bolted on to help it survive in the body and reach the brain. It is studied as a neurogenic and neurotrophic compound for Alzheimer's disease and other memory disorders, with the appeal of getting CNTF-like benefits in a small, orally available molecule. The honest status: it looks genuinely promising in mouse models, but the entire evidence base comes from a single research group and there are no human trials.
Also: Eye Peptide Bioregulator, Retina Peptide
Normoftal is an obscure Russian eye supplement from the Khavinson 'peptide bioregulator' tradition, sold as short peptides meant to support the retina. Be clear-eyed about this one: it is marketed as a dietary supplement, not an approved drug, and the evidence behind it is thin and comes almost entirely from one research lineage. We keep the claims minimal on purpose.
Key Comparison Insights
- Both peptides belong to the Cognitive category, suggesting similar primary applications.
- Normoftal has stronger research evidence (Human Trials) compared to P21 (Animal Studies).
Detailed Comparison
| Attribute | P21 | Normoftal |
|---|---|---|
| Category | Cognitive | Cognitive |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | P21 is a peptidergic CNTF mimetic, meaning it was designed to copy the active part of the natural neurotrophic factor CNTF without the downsides of the full protein. In rodent studies it boosts neurogenesis in the dentate gyrus of the hippocampus and raises brain-derived neurotrophic factor (BDNF), apparently by inhibiting leukemia inhibitory factor (LIF) signaling. Higher BDNF in turn dampens the activity of GSK-3 beta, a major enzyme that drives abnormal tau phosphorylation, which is the proposed link to reduced Alzheimer-type pathology. These are real findings in animals, but the framing of P21 as a clean single-pathway BDNF booster is a simplification of a still-incomplete picture. | Khavinson's bioregulator theory holds that very short peptides (two to four amino acids) extracted from or modeled on a specific tissue can act as tissue-specific signals, switching gene expression and protein synthesis back toward normal in that organ. Normoftal is the eye/retina version, described as containing a synthesized peptide (marketed as 'AKS-G,' reportedly lysine and glutamic acid) intended to support retinal cells. The proposed mechanism is that the peptide corrects an age- or disease-related 'peptide deficiency' and restores normal cellular function in the retina. This is a hypothesis from one school of research, not a mechanism confirmed by independent molecular studies, and the specific composition claims come from vendors rather than peer-reviewed identification. |
| Common Dosing | Limited community data available See research protocols | 2 capsules 1-2x daily 1-2x daily, before meals |
| Administration | Oral (nasal in some studies) | Oral capsules, before meals |
| Typical Duration | Ongoing supplementation in studies | 30-day courses, repeat after 2-6 months |
| Best Time to Take | Morning | Morning and evening, before meals |
Possible Side Effects May vary by individual |
|
|
| Research Summary | The research record on P21 is preclinical and concentrated in the work of Iqbal, Kazim and colleagues. In a 3xTg triple-transgenic mouse model of Alzheimer's disease, chronic oral P021 reduced tau hyperphosphorylation, increased BDNF, enhanced neurogenesis and improved memory performance (J Alzheimers Dis, 2014). Later work in the same line showed P021 prevented dendritic and synaptic deficits and cognitive impairment in animal models, and related studies extended it to Down syndrome and CDKL5 deficiency mouse models. The consistent thread is that across multiple rodent disease models the compound improves synaptic and cognitive measures with a favorable tolerability profile in those animals. The major limitation is that there are no published human clinical trials, no human safety data, and the evidence comes largely from one collaborating group, so independent replication and any translation to people remain open questions. | Normoftal is sold in Russia as a dietary supplement and is marketed for retinal degeneration, glaucoma, cataracts, diabetic retinopathy, and post-surgical recovery. Here is the part that matters most: it is not FDA-approved, and the evidence for Khavinson-style retinal bioregulators is heavily concentrated within Khavinson's own institute and clinical program, not replicated by independent international groups to modern standards. The related pharmaceutical Retinalamin is registered for clinical use in Russia, but that registration reflects the Russian system, not FDA or EMA review. There are essentially no rigorous, independent, placebo-controlled trials specific to Normoftal itself in mainstream literature. Treat the marketed eye-health benefits as unproven claims, and treat confidence in this compound as low. |
Frequently Asked Questions: P21 vs Normoftal
What is the difference between P21 and Normoftal?
P21 is a cognitive peptide that p21 (also written p021) is a small synthetic peptide reverse-engineered from the most active region of ciliary neurotrophic factor (cntf), with an adamantane group bolted on to help it survive in the body and reach the brain. it is studied as a neurogenic and neurotrophic compound for alzheimer's disease and other memory disorders, with the appeal of getting cntf-like benefits in a small, orally available molecule. the honest status: it looks genuinely promising in mouse models, but the entire evidence base comes from a single research group and there are no human trials. Normoftal is a cognitive peptide that normoftal is an obscure russian eye supplement from the khavinson 'peptide bioregulator' tradition, sold as short peptides meant to support the retina. be clear-eyed about this one: it is marketed as a dietary supplement, not an approved drug, and the evidence behind it is thin and comes almost entirely from one research lineage. we keep the claims minimal on purpose. The main differences lie in their mechanisms of action and clinical applications.
Which is better, P21 or Normoftal?
Neither is universally "better" - the choice depends on your specific goals. P21 is typically used for cognitive purposes, while Normoftal is used for cognitive. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can P21 and Normoftal be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using P21 and Normoftal together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.